Coronary artery by-pass surgery patients MedDRA version: 14.1 Level: LLT Classification code 10011076 Term: Coronary artery atherosclerosis System Organ Class: 10007541 - Cardiac disorders
Conditions
Interventions
Trade Name: Metoprolin
Product Name: Metoprolin
Product Code: 10456
Pharmaceutical Form: Tablet
CAS Number: 125-04-2
Other descriptive name: HYDROCORTISONE SODIUM SUCCINATE
Trade Name: Solu-Cortef
Pr
Sponsors
Juha Hartikainen
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 20 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 10
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary end point(s): concentration of metoprolol in plasma after dosage of the drug, difference between study and placebo group;Timepoint(s) of evaluation of this end point: metoprolol level in plasma 4, 6, 8, and 12 hours after administration, same protocol 4 days postoperatively;Main Objective: Patients;Secondary Objective: None | — |
Secondary
| Measure | Time frame |
|---|---|
| Timepoint(s) of evaluation of this end point: none | — |
Countries
Finland
Outcome results
None listed